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Two new sesquiterpenes, sarcandralactones A (1) and B (2), and five new dimeric sesquiterpenoids, sarcandrolides
A-E (3-7), along with 10 known compounds were isolated from the whole plants of Sarcandra glabra. Their structures
were elucidated on the basis of spectroscopic analysis. Some of the new isolates exhibit significant cytotoxicities when
tested against a small panel of tumor cell lines.
The plants of the Chloranthaceae family are rich sources of
sesquiterpenoid oligomers, which have attracted considerable
interest due to the diverse structures and significant biological
activities, such as antifungal,1 cytotoxicity,2 and inhibition of cell
adhesion expression.3 In our recent study, a number of dimeric
sesquiterpenoids isolated from Chloranthus spicatus were found
to exhibit potent and selective inhibition of the delayed rectifier
(IK) K+ current.4,5 There are three species in the Sarcandra genus
of the Chloranthaceae family, which are mainly distributed in the
southeast of Asia. The plant Sarcandra glabra (Thunb.) Nakai, an
evergreen shrub growing in southern China, has been applied in
the system of Traditional Chinese Medicine (TCM) to treat
inflammation, bone fracture, and cancer.6,7 Previous chemical
investigations of this species have led to the isolation of hepato-
protective sesquiterpenes and sesquiterpenoid glycosides.8 In this
study, two new sesquiterpenes, sarcandralactones A (1) and B (2),
and five new dimeric sesquiterpenoids, sarcandrolides A-E (3-7),
along with 10 known compounds were isolated from the whole
plants of S. glabra. We present herein the isolation, structural
elucidation, and cytotoxic evaluation of these new isolates.
Results and Discussion
The HREIMS of sarcandralactone A (1) displayed a molecular
ion at m/z 246.1241 [M]+, consistent with the molecular formula
of C15H18O3 requiring seven degrees of unsaturation. The IR
spectrum indicated the presence of hydroxy (3439 cm-1) and
carbonyl (1720 cm-1) groups. Its 1H NMR spectrum displayed a
characteristic upfield shifted resonance at δH 0.69 diagnostic for
the cyclopropane ring of lindenane sesquiterpenoids,9-11 two methyl
singlets, and two resonances at δH 5.08 (s) and 4.97 (s) for a terminal
double bond (Table 1). All 15 carbons were resolved in the 13C
NMR spectrum and were categorized by DEPT experiments as two
methyl, four methylene (one olefinic), three methine (one oxygen-
ated), and six quaternary carbons (one oxygenated, three olefinic,
and one ester carbonyl) (Table 1). These functionalities accounted
for three out of the seven degrees of unsaturation, and the remaining
four degrees of unsaturation implied compound 1 to be tetracyclic.
The 1H and 13C NMR data of 1 were similar to those of
heterogorgiolide,9 indicating a lindena-4(15)-en-12,8-olide structural
moiety for 1, which was confirmed by the HMBC spectrum. In
this experiment, the key correlations from the two protons of the
exocyclic double bond [δH 5.08 (s) and 4.97 (s)], the protons of
CH2-6 [δH 3.18 (d, J ) 15.0 Hz) and 2.42 (d, J ) 15.0 Hz)], and
the angular methyl at δH 1.30 (s, 3H) to the same oxygenated
quaternary carbon at δC 80.3 placed the hydroxy group at C-5
(Figure 1a).
The relative configuration of 1 was established on the basis of a
ROESY spectrum (Figure 1b), in which correlations of H3-14/H-
2 and H3-14/H-8 revealed that H3-14, H-8, and the cyclopropane
ring were cofacial and were arbitrarily assigned a -orientation.
Consequently, H-1 and H-3 were assigned as R-oriented. The
configuration of the C-5 stereocenter could not be assigned by the
ROESY spectrum since no correlation could be detected. To assign
the relative configuration of C-5, the pyridine-induced solvent shift
method was applied.12 The 1H NMR data of 1 measured in CDCl3
and pyridine-d5 showed significant pyridine-induced solvent shifts
[∆δ is defined as δ(CDCl3) - δ(pyridine-d5)] for H-2 (∆δ )
-0.52), H3-14 (∆δ ) -0.15), H-6R (∆δ ) -0.21), and H-6 (∆δ
) -0.22), indicating that the 5-OH was -oriented. Therefore, the
structure of 1 was elucidated as depicted.
Sarcandralactone B (2), a colorless solid, showed a molecular
formula of C15H20O3 ([M]+ m/z 248.1411) with six degrees of
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unsaturation by HREIMS. The IR spectrum showed absorption
bands for the presence of hydroxy and carbonyl groups. The 13C
NMR spectrum displayed 15 carbon signals comprising three
methyl, three methylene, three sp3 methine (two oxygenated), one
sp3 quaternary carbon, one ester carbonyl at δC 174.8, and four
olefinic carbons (Table 1). Its 1H NMR spectrum showed three
methyl singlets at δH 0.95, 1.70, and 1.84, two oxymethines at δH
3.56 (dd, J ) 9.6, 6.3 Hz) and 4.90 (dd, J ) 12.1, 6.8 Hz), and
one olefinic proton at δH 5.38 (br s) (Table 1). The above
spectroscopic analysis indicated that 2 is likely a eudesmadien-
12,8-olide. In the HMBC spectrum (Figure 2a), the correlations
from the upfield methyl singlet (δH 0.95) to C-1 (δC 74.9), C-5,
C-9, and C-10 placed the hydroxy group at C-1; the correlations
from H3-15 (δH 1.70) to C-3 (δC 121.1), C-4(δC 132.9), and C-5
indicated the ∆3 double bond; and the correlations from H-8 to
C-7, C-9, and C-11 as well as the correlations from H3-13 to C-7,
C-11, and C-12 confirmed the presence of a γ-lactone moiety
between C-12 and C-8. In the ROESY spectrum of 2 (Figure 2b),
the correlations of H-1/H-5, H-5/H-6R, and H-1/H-9R indicated
that they were cofacial and were arbitrarily assigned as R-oriented.
Consequently, the ROESY correlations of H3-14/H-8, H3-14/H-6,
and H-8/H-6 indicated that they were -oriented. Compound 2
was thus assigned as 1-hydroxy-3,7(11)-eudesmadien-12,8-olide.
Sarcandrolide A (3) was isolated as a colorless solid. The
HREIMS gave a molecular ion at m/z 618.2827 corresponding to
the molecular formula C36H42O9. The IR absorptions revealed the
presence of carbonyl and hydroxy functionalities. In accord with
the molecular formula, 36 carbon resonances were well resolved
in the 13C NMR spectrum (Table 3) and were categorized by DEPT
experiments as four carbonyl (δC 200.4, 173.4, 170.7, and 168.3),
eight olefinic carbons (three persubstituted and one trisubstituted
double bond), seven methyl (one O-methyl), five sp3 methylene
(one oxygenated), eight sp3 methine (one oxygenated), and four
sp3 quaternary carbons (two oxygenated). Its 1H NMR spectrum
showed two strongly upfield shifted resonances at δH 0.28 and 0.70
being interpreted in terms of cyclopropane rings (Table 2). The
NMR data of 3 showed close resemblance to those of shizukaol
C13 except for the significant changes of C-13′ and H-13′, which
indicated the presence of a C-13′ methyl group in 3 instead of an
oxygenated methylene in shizukaol C.13 This was confirmed by
the HMBC correlations from H3-13′ to C-7′, C-11′, and C-12′.
Analysis of the HMBC spectrum finalized the planar structure of 3
(Figure 3a). The relative configuration of 3 was established by a
ROESY experiment (Figure 3b). The ROESY correlations of H-1/
H-3, H-1/H-2R, H-1/H-9, H-5′/H-9, H-3′/H2-15′, and H-5′/H2-15′
indicated that they were cofacial and were arbitrarily assigned as
R-oriented. As a consequence, the ROESY correlations of H3-14/
H-2, H3-14/H-6, H-6/H-9′, and H-9′/H3-14′ revealed that they were
-oriented. Thus, compound 3 was determined as 13′-deoxyshi-
zukaol C.
The HRESIMS of sarcandrolide B (4) displayed a sodiated
molecular ion peak at m/z 673.2632 [M + Na]+, consistent with
the molecular formula C36H42O11. Its 13C NMR spectrum showed
similarities to that of shizukaol C,13 except for the absence of one
olefinic methyl group and the presence of one additional oxygenated
methylene in 4 (Table 3). Comparing the 1H NMR data of 4 with
that of shizukaol C,13 the olefinic proton H-3′′ resonated as a broad
triplet at δH 6.90 (br t, J ) 6.0 Hz) in 4 (Table 2), while it was a
double quartet at δH 6.88 (qq, J ) 7.1, 1.0 Hz) in shizukaol C,13
suggesting that C-4′′ of 4 was an oxygenated methylene. The
HMBC correlations from H2-4′′ at δH 4.26 (dd, J ) 15.0, 4.9 Hz)
and δH 4.44 (dd, J ) 15.0, 7.0 Hz) to C-2′′ and C-3′′ confirmed
this speculation. The relative configuration of 4 was fixed by the
ROESY spectrum, which resulted in the same assignment as
shizukaol C in the dimeric core.
Sarcandrolide C (5) was assigned the molecular formula
C42H46O15 on the basis of HRESIMS (m/z 813.2715 [M + Na]+).
The 1H NMR data exhibited the characteristic upfield shifted
resonances (δH 0.34 and 0.71) of cyclopropane rings (Table 2),
indicating that compound 5 is also likely a lindenane-type sesquit-
Table 1. 1H NMR (400 MHz) and 13C NMR Data (100 MHz) of 1 and 2
1 2
no. δH mult (J in Hz)a δH mult (J in Hz)b δCa δH mult (J in Hz)a δCa
1 1.45 m 1.34 ddd (8.1, 6.0, 4.3) 31.7 3.56 dd (9.6, 6.3) 74.9
2 0.69 dt (4.5, 8.1), 1.53 m 0.65 dt (4.1, 8.4), 2.05 m 13.9 2.02 m, 2.34 m 32.3
3 1.84 m 1.84 ddd (8.8, 6.1, 3.3) 20.9 5.38 br s 121.1
4 153.8 132.9
5 80.3 1.99 m 47.3
6 3.18 d (15.0) 3.40 d (14.5) 32.8 2.20 t (13.8) 25.3
2.42 d (15.0) 2.63 d (14.5) 2.91 dd (13.8, 3.8)
7 159.1 162.9
8 4.69 dd (12.5, 5.3) 4.81 dd (12.5, 5.7) 77.2 4.90 dd (12.1, 6.8) 78.4
9 2.34 dd (5.3, 12.5) 2.32 dd (12.5, 5.7) 45.1 0.98 t (12.1) 42.0




13 1.79 s, 3H 1.80 s, 3H 8.3 1.84 s, 3H 8.3
14 1.30 s, 3H 1.45 s, 3H 17.2 0.95 s, 3H 10.0
15 5.08 s, 4.97 s 5.05 s, 5.02 s 106.4 1.70 s, 3H 20.8
a Measured in CDCl3. b Measured in pyridine-d5.
Figure 1. Selected HMBC correlations (HfC) and key ROESY
correlations (HTH) of 1.
Figure 2. Selected HMBC correlations (HfC) and key ROESY
correlations (HTH) of 2.
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erpenoid dimer. The 13C NMR data of 5 showed similarity to those
of shizukaol G,14 except for the presence of two additional signals
(δC 169.9 and 20.7) being assignable to the presence of an acetyl
group in 5 (Table 3). The O-acetyl group was located at C-2′′′ by
the HMBC correlation between H-2′′′ (δH 5.48, dd, J ) 4.8, 3.3
Hz) and the carbonyl carbon (δC 169.9) of the acetyl group. Thus
sarcandrolide C (5) was determined as 2′′′-O-acetylshizukaol G.
The HREIMS of sarcandrolide D (6) exhibited a molecular ion
peak at m/z 678.2666 [M]+, corresponding to the molecular formula
C37H42O12. The 1H NMR spectrum showed characteristic proton
resonances for cyclopropane rings and six methyl groups, which
were classified according to the chemical shifts as two angular (δH
0.81 and 0.96), three olefinic [δH 1.53 (s), 1.78 (d, J ) 7.0 Hz),
and 1.78 (s)], and one acetyl methyl [δH 2.03 (s)] (Table 2). The
13C NMR spectrum displayed 37 carbon resonances comprising six
methyl, six methylene (two oxygenated), seven sp3 methine (one
oxygenated), eight olefinic (three tetrasubstituted and one trisub-
stituted double bonds), four ester carbonyl, and six sp3 quaternary
carbons (three oxygenated and one hemiacetal at δC 103.4) (Table
3). Comparison of its 13C NMR data with those of 3-5 showed
several changes in the dimeric core, suggesting that this part of the
structure of 6 is different from those of 3-5. Comparison of its
13C NMR data with those of chlorahololide F5 showed that the two
compounds were structurally close, except for the presence of one
oxygenated methine (C-9) in 6 instead of the keto carbonyl C-9 in
chlorahololide F. The HMBC correlations from H3-14 (δH 0.81,
3H) to C-1, C-5, C-9 (δC 78.3), and C-10 revealed that a hydroxy
group was located at C-9 of 6, replacing the C-9 keto group of
chlorahololide F. The planar structure of 6 was further verified by
the HMBC spectrum (Figure 4a). Its relative configuration was
assigned by a ROESY spectrum (Figure 4b), in which the OH-9
was fixed as -oriented by the ROESY cross-peak between H-9
and H-1. The relative configuration of the remaining stereocenters
of 6 was determined to be the same as chlorahololide F by their
similar NMR data and the ROESY spectrum.
Sarcandrolide E (7) had the molecular formula C38H44O12, as
determined by HREIMS at m/z 692.2805 [M]+. Its 1H and 13C NMR
spectra showed close resemblance to those of 6, indicating that they
are structurally related analogues. The NMR data of 7 compared
with 6 revealed the presence of one keto carbonyl (δC 198.9) and
one O-methyl group and the absence of the hemiacetal moiety,
suggesting that compound 7 was likely produced by the metha-
nolysis of the 8,12-lactone ring of 6. This speculation was confirmed
by the HMBC correlations from H-9 to C-10 and C-8 (δC 198.9)
and between OCH3 (δH 3.76) and C-12 (δC 169.6). The relative
configuration of 7 was established to be the same as 6 by the
ROESY spectrum.
The absolute configurations of 3-7 were determined by applying
the CD exciton chirality method.15 All five sesquiterpenoid dimers
showed a similar CD split pattern in the 210-260 nm region, where
positive chirality arose from the exciton coupling of the R,-
unsaturated γ-lactone (C-7′, C-11′, and C-12′) and twisted π-elec-
tron system [(C-5-C-8 and C-11-C-12) or (C-7-C-8 and C-11-C-
12)] chromophores (Figure 5). The CD spectra of 3-7 also matched
very well with those of reported sesquiterpenoid dimers,5 supporting
these assignments. The absolute configuration of 3-7 was therefore
assigned as depicted.
Ten known compounds were identified on the basis of their 1H
and 13C NMR and ESIMS data as (+)-spathulenol,16 chlorantha-
lactone E,17 neolitacumone B,18 3-eudesmene-1,7,11-triol,19 chlo-
rahololide F,5 shizukaol B,13 shizukaol C,13 shizukaol E,14 shizukaol
G,14 and cycloshizukaol A.20
The cytotoxic activities of compounds 1-7 were evaluated
against the HL-60 (human leukemia) cell line by using the MTT
method21 and against the A-549 (human lung adenocarcinoma) and
BEL-7402 (human hepatocarcinoma) cell lines by using the SRB
method,22 and with pseudolaric acid B23 as the positive control
(IC50 ) 4.2 µM against HL-60, 1.6 µM against A-549, and 1.3 µM
against BEL-7402). The results revealed that compounds 3-5
showed inhibitory activities against the HL-60 cell line with IC50
values of 3.1, 8.4, and 8.5 µM, respectively, compounds 3 and 5
showed inhibitory activities against the A-549 cell line with IC50
values of 7.2 and 4.7 µM, respectively, while none of the tested
compounds showed inhibitory activity on the BEL-7402 cell line.
Table 2. 1H NMR Data (CDCl3, 400 MHz) of 3-7
δH mult (J in Hz)
no. 3 4 5 6 7
1 2.06 m 2.07 m 2.05 ddd (8.2, 5.7, 4.3) 1.85 m 1.96 m
2 0.28 m, 0.98 m 0.33 m, 0.99 m 0.34 m, 1.00 m 0.88 m, 1.08 m 0.94 m, 2H
3 1.83 m 1.86 m 1.84 m 1.78 m 1.82 m
6 3.88 d (3.0) 3.91 br s 3.93 d, (3.8)
9 3.95 s 3.91 s 3.85 s 3.86 s 3.72 s
13 1.82 s, 3H 1.91 s, 3H 1.89 s, 3H 1.53 s, 3H 1.73 s, 3H
14 1.00 s, 3H 1.01 s, 3H 1.01 s, 3H 0.81 s, 3H 1.04 s, 3H
15 2.57 d (16.8) 2.56 dd (16.6, 1.8) 2.56 ddd (16.5, 6.0, 3.8) 1.74 m 1.69 dd (13.5, 10.6)
2.74 d (16.8) 2.82 dd (16.6, 0.9) 2.77 dd (16.5, 5.0) 2.71 m 2.73 dd (13.6, 6.8)
1′ 1.54 m 1.64 m 1.61 m 1.55 m 1.54 m
2′ 0.70 m, 1.23 m 0.72 m, 1.31 (m) 0.71 m, 1.32 m 0.61 m, 1.16 m 0.60 m, 1.19 m
3′ 1.51 m 1.43 m 1.39 m 1.68 m 1.58 m
5′ 1.74 dd (14.2, 6.2) 1.90 m 1.90 m 2.16 m 1.54 m
6′ 2.22 dd (18.0, 6.2) 2.40 dd (18.6, 6.3) 2.31 dd (19.2, 6.2) 2.44 dd (17.6, 6.8) 2.30 dd (18.0, 6.4)
2.50 dd (18.0, 14.2) 2.82 dd (18.6, 13.6) 2.91 dd (19.2, 13.8) 2.85 m 2.88 dd (18.0, 13.5)
9′ 1.80 m 1.94 m 1.88 m 2.63 m 2.55 dd (10.4, 7.5)
13′ 1.80 s, 3H 4.34 d (15.3) 4.44 d (12.0) 4.76 d (12.8) 4.82 s, 2H
4.41 d (15.3) 5.39 d (12.0) 4.82 d (12.8)
14′ 0.83 s, 3H 0.87 s, 3H 0.79 s, 3H 0.96 s, 3H 0.94 s, 3H
15′ 3.85 d (11.9) 3.80 d (11.6) 3.67 d (12.0) 4.03 d (11.1) 3.85 d (11.3)
4.15 d (11.9) 4.38 d (11.6) 4.55 d (12.0) 4.07 d (11.1) 4.15 d (11.3)
3′′ 6.90 br q (6.6) 6.77 br t (6.0) 6.56 br t (6.0) 6.84 br q (7.0) 6.84 br q (7.0)
4′′ 1.85 d (6.6) 3H 4.26 dd (15.0, 4.9) 4.61 dd (14.0, 6.4) 1.78 d (7.0) 1.83 d (7.0)
4.44 dd (15.0, 7.0) 5.36 dd (14.0, 5.9)
5′′ 1.83 s, 3H 1.87 s, 3H 1.95 d (0.9) 1.78 s, 3H 1.84 s, 3H
2′′′ 5.48 dd (4.8, 3.3)
3′′′ 2.77 dd (14.3, 4.8)
3.49 dd (14.3, 3.3)
OMe 3.77 s, 3H 3.74 s, 3H 3.71 s, 3H 3.76 s, 3H
OAc 2.17 s, 3H 2.03 s, 3H 2.07 s, 3H
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Experimental Section
General Experimental Procedures. Optical rotations were measured
on a Perkin-Elmer 341 polarimeter. UV spectra were obtained on a
Shimadzu UV-2550 spectrophotometer. IR spectra were recorded on a
Perkin-Elmer 577 spectrometer with KBr discs. NMR spectra were
recorded on a Bruker AM-400 spectrometer. EIMS (70 eV) and
HREIMS were measured on a Finnigan MAT-95 mass spectrometer
in m/z (rel %), and ESIMS and HRESIMS were obtained on an Esquire
3000 plus (Bruker Daltonics) and a Waters-Micromass Q-TOF Ultima
Global electrospray mass spectrometer, respectively. All solvents used
were of analytical grade (Shanghai Chemical Plant, Shanghai, People′s
Republic of China). Silica gel (200-300 mesh), silica gel H60,
Sephadex LH-20 (Amersham Biosciences), reversed-phase C18 silica
gel (150-200 mesh, Merck), and MCI gel (CHP20P, 75-150 µm,
Mitsubishi Chemical Industries Ltd.) were used for column chroma-
tography. Precoated silica gel GF254 plates (Qingdao Haiyang Chemical
Co. Ltd. Qingdao, People′s Republic of China) were used for TLC.
Plant Material. The whole plants of Sarcandra glabra were
collected in June of 2005 from Hainan Province, P. R. China. The plant
was authenticated by Prof. S. M. Huang, Department of Biology, Hainan
University of China. A voucher specimen has been deposited in
Shanghai Institute of Materia Medica, SIBS, Chinese Academy of
Sciences (access number: SGWP-2005-1Y).
Extraction and Isolation. The air-dried powder of the plant material
(4 kg) was percolated with 95% EtOH (3 × 5 L) to give 400 g of
crude extract, which was dissolved in water (1 L) and partitioned
successively with petroleum ether and EtOAc. The EtOAc-soluble
fraction (90 g) was subjected to an MCI gel column (MeOH/H2O, 0%
to 100%) to give three fractions, 1-3. Fraction 1 (50 g) was separated
on a silica gel column (petroleum ether/acetone, 50:1 to 0:1) to afford
seven fractions, 1a-1g. Fraction 1b was chromatographed over a silica
gel column, eluted with petroleum ether/EtOAc, 20:1, to afford four
fractions, 1b1-1b4. Fraction 1b1 (150 mg) was purified on a Sephadex
LH-20 column, eluted with EtOH, to give (+)-spathulenol (80 mg);
fraction 1b3 (220 mg) gave neolitacumone B (70 mg) by the same
purification procedure. Fraction 1d (500 mg) was separated on a
reversed-phase C18 silica gel column (MeOH/H2O, 50% to 80%) to
afford two fractions, 1d1 and 1d2. Fraction 1d2 was purified by silica
gel column chromatography (petroleum ether/acetone, 10:1 to 8:1) to
give 1 (7 mg) and 2 (5 mg). Fraction 1e (8 g) was subjected to CC on
silica gel (CH2Cl2/MeOH, 200:1 to 20:1) to give five fractions,
1e1-1e5. Fraction 1e2 (870 mg) was subjected to a silica gel column
(petroleum ether/EtOAc, 8:1) to afford chloranthalactone E (230 mg).
Fraction 1e3 (2.6 g) was chromatographed over a column of reversed-
phase C18 silica gel (MeOH/H2O, 50% to 80%) to afford four fractions,
1e3a-1e3d. Fraction 1e3a (780 mg) was separated over a silica gel
column (petroleum ether/acetone, 8:1 to 3:1), followed by preparative
TLC (CH3Cl/MeOH, 30:1), to afford 3 (5 mg), 4 (30 mg), 5 (5 mg),
and chlorahololide F (23 mg). Fraction 1e3b (430 mg) was separated
over a silica gel column (petroleum ether/acetone, 8:1 to 6:1), followed
by the purification on a Sephadex LH-20 column (EtOH), to give
3-eudesmene-1,7,11-triol (30 mg). Fraction 1e3d (370 mg) was
separated on a silica gel column (petroleum ether/acetone, 8:1) and
then purified by preparative TLC (CH3Cl/MeOH, 30:1) to afford
cycloshizukaol A (60 mg). Fractions 1e4 (1.6 g) was chromatographed
over a column of reversed-phase C18 silica gel (MeOH/H2O, 50% to
80%) to give three fractions, 1e4a-1e4c. Fraction 1e4a (220 mg) was
chromatographed on a silica gel column (petroleum ether/acetone, 8:1
to 6:1), followed by a Sephadex LH-20 column (EtOH), to yield 6 (33
mg), 7 (4 mg), and shizukaol B (16 mg). Fraction 1e4b (670 mg) was
Table 3. 13C NMR Data (CDCl3, 100 MHz) of 3-7
δC
no. 3 4 5 6 7
1 25.6 26.1 26.2 29.0 25.8
2 15.9 16.0 16.0 9.3 8.6
3 24.7 24.8 24.8 29.8 29.8
4 142.3 142.6 142.6 77.7 79.1
5 131.9 132.2 132.4 164.5 163.1
6 40.7 41.2 41.2 122.5 124.7
7 131.5 146.4 131.3 152.4 142.3
8 200.4 200.7 200.7 103.4 198.9
9 80.3 79.7 79.7 78.3 77.7
10 51.1 50.8 50.8 49.6 50.7
11 147.4 131.9 146.8 124.0 128.8
12 170.7 171.8 170.1 171.4 169.6
13 20.2 20.1 19.8 10.3 21.0
14 15.2 15.5 15.5 14.0 15.6
15 25.3 25.3 25.3 40.1 41.2
1′ 25.3 25.6 25.7 26.5 26.8
2′ 12.0 11.5 11.4 10.5 10.3
3′ 28.3 27.7 28.0 29.6 29.2
4′ 77.6 77.4 77.1 77.3 77.3
5′ 60.3 60.8 60.9 52.7 55.1
6′ 22.0 23.1 24.3 21.4 22.4
7′ 165.1 168.2 174.8 171.5 170.2
8′ 92.6 93.0 93.5 85.4 87.2
9′ 55.4 54.5 55.4 51.0 53.0
10′ 44.6 44.8 45.1 44.5 44.9
11′ 124.7 127.2 123.6 123.0 124.9
12′ 173.4 172.2 171.8 171.0 170.4
13′ 8.6 55.0 53.7 55.2 55.1
14′ 26.2 26.1 25.9 24.1 24.2
15′ 70.7 72.3 72.6 70.6 70.6
1′′ 168.3 167.5 167.3 168.6 168.1
2′′ 128.0 127.4 129.4 128.0 127.9
3′′ 138.8 141.9 135.4 138.9 138.8
4′′ 12.1 59.6 61.7 12.0 12.1





OMe 52.5 53.2 52.5 52.6
OAc 169.9 170.7 170.5
20.7 20.5 20.4
Figure 3. Selected HMBC correlations (HfC) and key ROESY
correlations (HTH) of 3.
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separated in the same way as 1e4a to afford shizukaol C (18 mg),
shizukaol E (30 mg), and shizukaol G (6 mg).
Sarcandralactone A (1): colorless gum; [R]20D +168 (c 0.1, MeOH);
UV (MeOH) λmax (log ε) 209 (4.33) nm; IR (KBr) νmax 3439, 2999,
2929, 1720, 1687, 1452, 1387, 1109, 1016, 893 cm-1; 1H NMR data,
see Table 1; 13C NMR data, see Table 1; EIMS 70 eV m/z (relative
intensity) 246 [M]+ (28), 228 (33), 201 (38), 132 (40), 110 (59), 107
(64), 91 (100), 77 (73), 53 (51); HREIMS m/z 246.1241 (calcd for
C15H18O3, 246.1256).
Sarcandralactone B (2): colorless solid; [R]20D +18 (c 0.1, MeOH);
UV (MeOH) λmax (log ε) 217 (4.04) nm; IR (KBr) νmax 3444, 2926,
1732, 1682, 1441, 1387, 1221, 1109, 1036, 754 cm-1; 1H NMR data,
see Table 1; 13C NMR data, see Table 1; EIMS 70 eV m/z (relative
intensity) 248 [M]+ (100), 230 (21), 178 (83), 160 (19), 133 (41), 105
(20), 84 (28), 71 (15), 55 (9); HREIMS m/z 248.1411 (calcd for
C15H20O3, 248.1412).
Sarcandrolide A (3): colorless solid; [R]20D -120 (c 0.1, MeOH);
UV (MeOH) λmax (log ε) 217 (4.41) nm; CD (MeOH) λmax (∆ε) 344
(-2.74), 260 (8.64), 219 (-10.00) nm; IR (KBr) νmax 3446, 2949, 1738,
1649, 1437, 1381, 1267, 1134, 993 cm-1; 1H NMR data, see Table 2;
13C NMR data, see Table 3; EIMS 70 eV m/z (relative intensity) 618
[M]+ (1), 514 (4), 344 (10), 274 (26), 226 (100), 211 (39), 197 (22),
83 (84), 55 (48); HREIMS m/z 618.2827 (calcd for C36H42O9, 618.2829).
Sarcandrolide B (4): yellowish powder; [R]20D -75 (c 0.08, MeOH);
UV (MeOH) λmax (log ε) 216 (4.28) nm; CD (MeOH) λmax (∆ε) 341
(-3.38), 258 (10.82), 217 (-18.6) nm; IR (KBr) νmax 3439, 2933, 1734,
1651, 1437, 1379, 1277, 1136, 1086, 989 cm-1; 1H NMR data, see
Table 2; 13C NMR data, see Table 3; positive mode ESIMS m/z 673
[M + Na]+; HRESIMS m/z 673.2632 (calcd for C33H38O10Na,
673.2625).
Sarcandrolide C (5): colorless solid; [R]20D -92 (c 0.1, MeOH);
UV (MeOH) λmax (log ε) 218 (4.43) nm; CD (MeOH) λmax (∆ε) 346
(-1.78), 251 (6.76), 207 (-12.4) nm; IR (KBr) νmax 3452, 2939, 1751,
1711, 1664, 1616, 1373, 1200, 1161 cm-1; 1H NMR data, see Table 2;
13C NMR data, see Table 3; positive mode ESIMS m/z 813 [M + Na]+;
negative mode ESIMS m/z 789 [M - H]-; HRESIMS m/z 813.2715
(calcd for C33H38O10Na, 813.2734).
Sarcandrolide D (6): colorless solid; [R]20D -26 (c 0.1, MeOH);
UV (MeOH) λmax (log ε) 216 (4.44) nm; CD (MeOH) λmax (∆ε) 273
(18.14), 247 (11.82), 216 (-31.64) nm; IR (KBr) νmax 3450, 2939,
1751, 1686, 1443, 1383, 1267, 1082, 968 cm-1; 1H NMR data, see
Table 2; 13C NMR data, see Table 3; EIMS 70 eV m/z (relative
intensity) 678 [M]+ (62), 660 (80), 642 (100), 556 (58), 512 (61), 482
(60), 410 (76), 379 (77), 223 (55); HREIMS m/z 678.2666 (calcd for
C37H42O12, 678.2676).
Sarcandrolide E (7): colorless solid; [R]20D -91 (c 0.1, MeOH);
UV (MeOH) λmax (log ε) 218 (4.48) nm; CD (MeOH) λmax (∆ε) 341
(-6.68), 262 (22.76), 221 (-14.20) nm; IR (KBr) νmax 3466, 2937,
1751, 1709, 1648, 1437, 1265, 1132, 972 cm-1; 1H NMR data, see
Table 2; 13C NMR data, see Table 3; EIMS 70 eV m/z (relative
intensity) 692 [M]+ (1), 660 (3), 642 (18), 482 (8), 410 (8), 377 (8),
223 (4), 83 (100), 55 (44); HREIMS m/z 692.2805 (calcd for C38H44O12
692.2833).
Cytotoxicity Assay. Cytotoxic activities were evaluated against the
HL-60 cell line by using the MTT method21 and against the A-549
and BEL-7402 cell lines by using the SRB method,22 and pseudolaric
acid B23 was used as the positive control (for details see the Supporting
Information).
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